Pharmacotherapy of Epilepsy
Introduction Epilepsy, a chronic neurological disorder characterized by recurrent seizures, affects millions…
Pharmacotherapy of Peptic Ulcer Disease (PUD)
Introduction Peptic ulcer disease (PUD) encompasses the formation of ulcers in the stomach (gastric ulcer) or duodenum (duodenal…
Pharmacotherapy of Bronchial Asthma
Introduction Asthma is a chronic inflammatory disease of the airways, characterized by bronchial hyperresponsiveness, variable airflow obstruction,…
Pharmacotherapy of Cough
Introduction Cough is a protective reflex integral to clearing the airways of irritants, secretions, and foreign…
Pharmacotherapy of Parkinson’s Disease
Introduction Parkinson’s disease (PD) is a common neurodegenerative disorder characterized predominantly by motor symptoms including bradykinesia, rest tremor, rigidity,…
Pharmacology of Sedative-Hypnotics
Introduction Sedative-hypnotics are a class of medications primarily utilized to induce sedation…
Pharmacotherapy of Antidepressants
Introduction Antidepressant medications are a cornerstone of modern psychiatric care, offering relief…
Pharmacotherapy of Tuberculosis (TB)
Introduction Tuberculosis (TB) is a potentially severe infectious disease caused primarily by…
Pharmacotherapy of Glaucoma
Introduction Glaucoma is a group of progressive ocular disorders characterized by damage…
Pharmacology of Sympathomimetics: Mechanisms, Clinical Applications, and Safety
Introduction to Sympathomimetics Sympathomimetic medications—also known as adrenergic agonists—are a diverse group…
